(NEXSTAR) – GLP-1 drugs, which have grown incredibly popular in recent years for their ability to help people lose substantial weight, are now friendlier to needle-phobes. The class of medications, ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

Sam Hargrave helms the sequel for the action franchise that launched in 2020. By Ryan Gajewski Senior Entertainment Reporter The streaming service announced Wednesday that the third movie in the ...

EXCLUSIVE: Tyler Rake looks ready for his next mission. Sources tell Deadline that Chris Hemsworth has closed a deal to reprise his role in Extraction 3, the new installment in the hit Netflix and ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Mercenary: An Extraction Series, the TV spinoff of Netflix’s Chris Hemsworth-led action thriller movie franchise, has wrapped production in Ireland and is now heading to Morocco. But the streamer is ...

Miller Reynolds is a Writer at DualShockers specializing in news, reviews, guides, interviews, and lists. He began covering games professionally in 2025, bringing a journalism background and more than ...

In his new book, antitrust scholar and former White House adviser Tim Wu argues that tech giants are bleeding you dry—and lays out a plan to stop them. The relationship is worth mentioning because ...